Immunisation with a multivalent, subunit vaccine reduces patent infection in a natural bovine model of onchocerciasis during intense field exposure.
Human onchocerciasis, caused by the filarial nematode Onchocerca volvulus, is controlled almost exclusively by the drug ivermectin, which prevents pathology by targeting the microfilariae. However, this reliance on a single control tool has led to interest in vaccination as a potentially complementa...
Saved in:
Main Authors: | Benjamin L Makepeace (Author), Siv Aina Jensen (Author), Sandra J Laney (Author), Charles K Nfon (Author), Leo M Njongmeta (Author), Vincent N Tanya (Author), Steven A Williams (Author), Albert E Bianco (Author), Alexander J Trees (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2009-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resolution of Eczema with Multivalent Peptides
by: Laura L. Eggink, et al.
Published: (2022) -
The Onchocerciasis Vaccine for Africa--TOVA--Initiative.
by: Peter J Hotez, et al.
Published: (2015) -
Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery
by: José Antonio Lebrón, et al.
Published: (2021) -
AlbuCORE: an albumin-based molecular scaffold for multivalent biologics design
by: Mario Sanches, et al.
Published: (2020) -
Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis.
by: Pedro Cecílio, et al.
Published: (2017)